The frequency of lysosomal acid lipase deficiency in children with unexplained liver disease
dc.contributor.author | Kuloglu, Zarife | |
dc.contributor.author | Kansu, Aydan | |
dc.contributor.author | Selbuz, Suna | |
dc.contributor.author | Kalayci, Ayhan G. | |
dc.contributor.author | Sahin, Gulseren | |
dc.contributor.author | Kirsaclioglu, Ceyda Tuna | |
dc.contributor.author | Demiroren, Kaan | |
dc.contributor.author | Dalgıç, Buket | |
dc.contributor.author | Kasırga, Erhun | |
dc.contributor.author | Önal, Zerrin | |
dc.contributor.author | İşlek, Ali | |
dc.contributor.author | National LAL-D Study Group | |
dc.date.accessioned | 2020-03-26T20:19:29Z | |
dc.date.available | 2020-03-26T20:19:29Z | |
dc.date.issued | 2019 | |
dc.department | Selçuk Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Objectives: Evidence suggests that lysosomal acid lipase deficiency (LAL-D) is often underdiagnosed because symptoms may be nonspecific. We aimed to investigate the prevalence of LAL-D in children with unexplained liver disease and to identify demographic and clinical features with a prospective, multicenter, cross-sectional study. Methods: Patients (aged 3 months-18 years) who had unexplained transaminase elevation, unexplained hepatomegaly or hepatosplenomegaly, obesity-unrelated liver steatosis, biopsy-proven cryptogenic fibrosis and cirrhosis, or liver transplantation for cryptogenic cirrhosis were enrolled. A Web-based electronic data collection system was used. LAL activity (nmol/punch/h) was measured using the dried blood spot method and classified as LAL-D(<0.02), intermediate (0.02-0.37) or normal (>0.37). Asecond dried blood spot sample was obtained from patients with intermediate LAL activity for confirmation of the result. Results: A total of 810 children (median age 5.6 years) from 795 families were enrolled. The reasons for enrollment were unexplained transaminase elevation (62%), unexplained organomegaly (45%), obesity-unrelated liver steatosis (26%), cryptogenic fibrosis and cirrhosis (6%), and liver transplantation for cryptogenic cirrhosis (<1%). LAL activity was normal in 634 (78%) and intermediate in 174 (21%) patients. LAL-D was identified in 2 siblings aged 15 and 6 years born to unrelated parents. Dyslipidemia, liver steatosis, and mild increase in aminotransferases were common features in these patients. Moreover, the 15-year-old patient showed growth failure and microvesicular steatosis, portal inflammation, and bridging fibrosis in the liver biopsy. Based on 795 families, 2 siblings in the same family were identified as LAL-D cases, making the prevalence of LAL-D in this study population, 0.1% (0.125%-0.606%). In the repeated measurement (76/174), LAL activity remained at the intermediate level in 38 patients. Conclusions: Overall, the frequency of LAL-D patients in this study (0.1%) suggests that LAL-D seems to be rare even in the selected high-risk population. | en_US |
dc.description.sponsorship | Alexion Pharmaceuticals Inc.Fukuda Foundation for Medical TechnologyKayamori FoundationKayamori Foundation of Informational Science AdvancementSENSHIN Medical Research FoundationSasagawa Scientific Research Grant | en_US |
dc.description.sponsorship | This investigator sponsored research was funded by Alexion Pharmaceuticals Inc. | en_US |
dc.identifier.citation | Kuloglu, Z., Kansu, A., Selbuz, S., Kalayci, A.G., Sahin, G., Kirsaclioglu, C.T., Demiroren, K., Dalgıç, B., Kasırga, E., Önal, Z., İşlek, A., National LAL-D Study Group.(2019). The Frequency of Lysosomal Acid Lipase Deficiency in Children With Unexplained Liver Disease. Journal Of Pedıatrıc Gastroenterology And Nutrıtıon, 68,(3), 371,376. | |
dc.identifier.doi | 10.1097/MPG.0000000000002224 | en_US |
dc.identifier.endpage | 376 | en_US |
dc.identifier.issn | 0277-2116 | en_US |
dc.identifier.issn | 1536-4801 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 30540705 | en_US |
dc.identifier.startpage | 371 | en_US |
dc.identifier.uri | https://dx.doi.org/10.1097/MPG.0000000000002224 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/38290 | |
dc.identifier.volume | 68 | en_US |
dc.identifier.wos | WOS:000461077600024 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | National LAL-D Study Group | |
dc.language.iso | en | en_US |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | en_US |
dc.relation.ispartof | JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | children | en_US |
dc.subject | liver | en_US |
dc.subject | lysosomal acid lipase deficiency | en_US |
dc.title | The frequency of lysosomal acid lipase deficiency in children with unexplained liver disease | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- National LAL-D Study Group.pdf
- Boyut:
- 175.82 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Full Text Access